Vetter Completes Schuetzenstrasse Facility

Vetter has completed construction of its 91,500 sq.-ft. Schuetzenstrasse multi-functional building. The €29 million investment is part of a €300 million investment strategy for further development of its manufacturing sites and additional manufacturing capacities. The Schuetzenstrasse building will support drug development and provide enhanced IT systems to meet future customer and regulatory requirements.
 
The facility contains non-cGMP labs for development support, lab space for microbiological analysis, office space for Vetter Development Service and IT as well as its data processing center with enhanced security systems, including a safety cell that protects technology and data from external physical hazards in the event of an emergency.
 
“With the installation of these future-oriented IT systems, we are early-on addressing the need for increased connectivity between customers and their manufacturing partners, like Vetter, to efficiently share and store data without concern for its safety,” said Oliver Albrecht, a Vetter managing director. “The new building is further evidence that Vetter is well-prepared to meet present and future industry challenges and requirements.”